Literature DB >> 21788589

MicroRNA-24 regulates vascularity after myocardial infarction.

Jan Fiedler1, Virginija Jazbutyte, Bettina C Kirchmaier, Shashi K Gupta, Johan Lorenzen, Dorothee Hartmann, Paolo Galuppo, Susanne Kneitz, John T G Pena, Cherin Sohn-Lee, Xavier Loyer, Juergen Soutschek, Thomas Brand, Thomas Tuschl, Joerg Heineke, Ulrich Martin, Stefan Schulte-Merker, Georg Ertl, Stefan Engelhardt, Johann Bauersachs, Thomas Thum.   

Abstract

BACKGROUND: Myocardial infarction leads to cardiac remodeling and development of heart failure. Insufficient myocardial capillary density after myocardial infarction has been identified as a critical event in this process, although the underlying mechanisms of cardiac angiogenesis are mechanistically not well understood. METHODS AND
RESULTS: Here, we show that the small noncoding RNA microRNA-24 (miR-24) is enriched in cardiac endothelial cells and considerably upregulated after cardiac ischemia. MiR-24 induces endothelial cell apoptosis, abolishes endothelial capillary network formation on Matrigel, and inhibits cell sprouting from endothelial spheroids. These effects are mediated through targeting of the endothelium-enriched transcription factor GATA2 and the p21-activated kinase PAK4, which were identified by bioinformatic predictions and validated by luciferase gene reporter assays. Respective downstream signaling cascades involving phosphorylated BAD (Bcl-XL/Bcl-2-associated death promoter) and Sirtuin1 were identified by transcriptome, protein arrays, and chromatin immunoprecipitation analyses. Overexpression of miR-24 or silencing of its targets significantly impaired angiogenesis in zebrafish embryos. Blocking of endothelial miR-24 limited myocardial infarct size of mice via prevention of endothelial apoptosis and enhancement of vascularity, which led to preserved cardiac function and survival.
CONCLUSIONS: Our findings indicate that miR-24 acts as a critical regulator of endothelial cell apoptosis and angiogenesis and is suitable for therapeutic intervention in the setting of ischemic heart disease.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21788589     DOI: 10.1161/CIRCULATIONAHA.111.039008

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  160 in total

Review 1.  Antisense MicroRNA Therapeutics in Cardiovascular Disease: Quo Vadis?

Authors:  Leonne E Philippen; Ellen Dirkx; Jan B M Wit; Koos Burggraaf; Leon J de Windt; Paula A da Costa Martins
Journal:  Mol Ther       Date:  2015-07-28       Impact factor: 11.454

Review 2.  Molecular mechanisms of ischemic preconditioning in the kidney.

Authors:  Pinelopi P Kapitsinou; Volker H Haase
Journal:  Am J Physiol Renal Physiol       Date:  2015-08-26

Review 3.  The non-coding road towards cardiac regeneration.

Authors:  James E Hudson; Enzo R Porrello
Journal:  J Cardiovasc Transl Res       Date:  2013-12       Impact factor: 4.132

Review 4.  Image-guided therapies for myocardial repair: concepts and practical implementation.

Authors:  Frank M Bengel; Richard T George; Karl H Schuleri; Albert C Lardo; Kai C Wollert
Journal:  Eur Heart J Cardiovasc Imaging       Date:  2013-05-29       Impact factor: 6.875

5.  Maternal pak4 expression is required for primitive myelopoiesis in zebrafish.

Authors:  Sheran H W Law; Thomas D Sargent
Journal:  Mech Dev       Date:  2012-09-29       Impact factor: 1.882

Review 6.  MicroRNAs in myocardial ischemia: identifying new targets and tools for treating heart disease. New frontiers for miR-medicine.

Authors:  V Sala; S Bergerone; S Gatti; S Gallo; A Ponzetto; C Ponzetto; T Crepaldi
Journal:  Cell Mol Life Sci       Date:  2013-11-12       Impact factor: 9.261

Review 7.  microRNA-200b as a Switch for Inducible Adult Angiogenesis.

Authors:  Mithun Sinha; Subhadip Ghatak; Sashwati Roy; Chandan K Sen
Journal:  Antioxid Redox Signal       Date:  2015-05-10       Impact factor: 8.401

8.  MicroRNA-26a regulates pathological and physiological angiogenesis by targeting BMP/SMAD1 signaling.

Authors:  Basak Icli; A K M Wara; Javid Moslehi; Xinghui Sun; Eva Plovie; Meghan Cahill; Julio F Marchini; Andrew Schissler; Robert F Padera; Jianru Shi; Hui-Wen Cheng; Srilatha Raghuram; Zoltan Arany; Ronglih Liao; Kevin Croce; Calum MacRae; Mark W Feinberg
Journal:  Circ Res       Date:  2013-09-18       Impact factor: 17.367

Review 9.  Non-coding RNAs in cardiovascular diseases: diagnostic and therapeutic perspectives.

Authors:  Wolfgang Poller; Stefanie Dimmeler; Stephane Heymans; Tanja Zeller; Jan Haas; Mahir Karakas; David-Manuel Leistner; Philipp Jakob; Shinichi Nakagawa; Stefan Blankenberg; Stefan Engelhardt; Thomas Thum; Christian Weber; Benjamin Meder; Roger Hajjar; Ulf Landmesser
Journal:  Eur Heart J       Date:  2018-08-01       Impact factor: 29.983

Review 10.  MicroRNAs in endothelial cell homeostasis and vascular disease.

Authors:  Carlos Fernández-Hernando; Yajaira Suárez
Journal:  Curr Opin Hematol       Date:  2018-05       Impact factor: 3.284

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.